The use of the immune system for the treatment of cancer is still zzso Recent advances in antigen presentation and recognition zzso and the characterization of zzso antigens generating a T cell response are crucial steps for the stimulation of research in this zzso These advances should allow the development of selective zzso either passive zzso of lymphocytes with specific recognition of autologous zzso or active zzso and the evaluation of this new approach in cancer treatment zzso 
